{"id":"https://openalex.org/W2099267285","doi":null,"title":"Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.","display_name":"Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.","publication_year":1981,"publication_date":"1981-10-01","ids":{"openalex":"https://openalex.org/W2099267285","mag":"2099267285","pmid":"https://pubmed.ncbi.nlm.nih.gov/7284997"},"language":"en","primary_location":{"id":"pmid:7284997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7284997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057163122","display_name":"Paul S. Ritch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P S Ritch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061043430","display_name":"Sandra J. Occhipinti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S J Occhipinti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108788441","display_name":"Robert E. Cunningham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R E Cunningham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027859218","display_name":"Stanley E. Shackney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S E Shackney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8518,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.70410043,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"41","issue":"10","first_page":"3881","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7445999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7445999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.06650000065565109,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medication-scheduling","display_name":"drug scheduling","score":0.5260000228881836},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8379999995231628},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.9480000138282776},{"id":"https://openalex.org/keywords/1-beta-d-arabinofuranosylcytosine","display_name":"1-beta-D-arabinofuranosylcytosine","score":0.9670000076293945},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6179999709129333},{"id":"https://openalex.org/keywords/sarcoma-180","display_name":"sarcoma 180","score":0.8600000143051147},{"id":"https://openalex.org/keywords/dna-histograms","display_name":"DNA histograms","score":0.4390000104904175},{"id":"https://openalex.org/keywords/cell-cycle-synchronization","display_name":"cell cycle synchronization","score":0.7070000171661377},{"id":"https://openalex.org/keywords/s-phase-arrest","display_name":"S phase arrest","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5293819308280945},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48552393913269043},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43918681144714355},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.41882413625717163},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4110392928123474},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28709298372268677},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.22790586948394775},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1859622299671173}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006918","descriptor_name":"Hydroxyurea","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012510","descriptor_name":"Sarcoma 180","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7284997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7284997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2099267285","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7284997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1486485340","https://openalex.org/W1493421090","https://openalex.org/W1493844622","https://openalex.org/W1508699674","https://openalex.org/W1517866590","https://openalex.org/W1519150126","https://openalex.org/W1590166159","https://openalex.org/W1602400698","https://openalex.org/W1754054975","https://openalex.org/W1953215572","https://openalex.org/W2004129482","https://openalex.org/W2065311388","https://openalex.org/W2092862127","https://openalex.org/W2106570552","https://openalex.org/W2119551409","https://openalex.org/W2149810874","https://openalex.org/W2152137893","https://openalex.org/W2170229658","https://openalex.org/W4406986647"],"related_works":["https://openalex.org/W2106570552","https://openalex.org/W2004129482","https://openalex.org/W1697067943","https://openalex.org/W2444131948","https://openalex.org/W2142890452","https://openalex.org/W1976236549","https://openalex.org/W2073527600","https://openalex.org/W2409392632","https://openalex.org/W2063463832","https://openalex.org/W2032138797"],"abstract_inverted_index":{"The":[0],"lethal":[1],"effects":[2],"of":[3,5,47,117,189],"combinations":[4,142],"adriamycin":[6],"(ADR)":[7],"and":[8,56,163,175],"either":[9,77,94,176],"hydroxyurea":[10],"(HU)":[11],"or":[12,49,79,96,178],"1-beta-d-arabinofuranosylcytosine":[13],"(ara-C)":[14],"were":[15,51,67,143,154],"studied":[16],"in":[17,22,27,36,145,150,191],"relation":[18],"to":[19,58,93,103,105],"drug-scheduling":[20,115],"interval":[21,116,125],"Sarcoma":[23],"180":[24],"cells":[25,190],"grown":[26],"vitro.":[28],"Drug":[29],"lethality":[30],"was":[31,73,84,89,100,111,128,135],"determined":[32],"by":[33,43,53,62,183],"cell":[34,60,81,98,184],"cloning":[35],"soft":[37],"agar.":[38],"Serial":[39],"kinetic":[40],"changes":[41,149],"induced":[42],"a":[44,114],"priming":[45],"dose":[46],"HU":[48,78,95,161,177],"ara-C":[50,167,179],"monitored":[52],"flow":[54],"cytometry":[55],"related":[57],"schedule-dependent":[59,109,120,171],"killing":[61,99],"ADR.":[63],"All":[64],"drug":[65,141],"exposures":[66],"for":[68],"1":[69],"hr.":[70,132],"When":[71],"ADR":[72,88,174],"given":[74,90,144],"together":[75],"with":[76,187],"ara-C,":[80,97],"log":[82],"kill":[83],"additive.":[85],"However,":[86],"when":[87,138],"after":[91,160,166],"exposure":[92,162],"increased":[101,129],"up":[102],"200-":[104],"500-fold,":[106],"respectively.":[107],"Maximum":[108],"synergism":[110,121,134,172],"observed":[112,137],"at":[113],"2":[118,131],"hr;":[119],"decreased":[122],"as":[123],"the":[124,139,151,170],"between":[126,173],"drugs":[127],"beyond":[130],"Schedule-dependent":[133],"not":[136,155],"same":[140],"reversed":[146],"order.":[147],"Drug-induced":[148],"DNA":[152],"histogram":[153],"seen":[156],"until":[157],"5":[158],"hr":[159,165],"8":[164],"exposure.":[168],"Thus,":[169],"cannot":[180],"be":[181],"explained":[182],"cycle":[185],"blockade":[186],"synchronization":[188],"S":[192],"phase.":[193]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}